An oncology journal has withdrawn a review article about the hypothetical link between Covid-19 and cancer after determining that the medical writer who authored the work did not do all the writing herself.
The paper, “Clinical sequelae of the new coronavirus: does COVID-19 infection predispose patients to cancer?” appears in Oncology of the future in May and was written by Priya Hays, who at the time was a technical writer at Talis Biomedical Corp. in Menlo Park, California. Hays is currently at Abbott, according to her LinkedIn profile. She also has a company called Hays Documentation Specialistswhich offers a variety of manuscript services, including academic writing and so-called “unstructured writing assistance”.
As the withdrawal notice indicates, Hays seems to have had his own editorial assistance:
Priya Hays’ review, “Clinical sequelae of the novel coronavirus: Does COVID-19 infection predispose patients to cancer?” », published in the July 2020 issue of Oncology of the future 16(20), 1463–1474 (2020), was found to contain significant portions of text plagiarized from other publications. In light of this, Oncology of the future removed the item.
The authors and editors of Oncology of the future I would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.
Hays did not respond to a request for comment.
The retraction brings our list of retracted COVID-19 articles to 41.
Like the retraction watch? You can do a tax-deductible contribution to support our workFollow us on Twitterlike us on Facebookadd us to your RSS readeror subscribe to our daily summary. If you find a retraction that is not in our databaseyou can let us know here. For feedback or feedback, email us at [email protected].